© 2018 John Wiley & Sons Ltd Background: Next generation sequencing (NGS) to detect actionable genetic abnormalities is standard of care in advanced stage lung adenocarcinoma. Many studies have shown that the molecular results obtained from fine needle aspiration cytology material are comparable to those obtained from formalin-fixed tissue samples. We undertook this study to validate DNA extraction from cytology material for molecular studies and to find any correlation between DNA yield, pattern of tumour cells and tumour fraction. Methods: DNA was extracted from 34 cytology slides of pulmonary adenocarcinoma cases with predetermined EGFR mutation status. Cytology slides were reviewed for pattern of tumour distribution and tumour fraction....
Molecular cytopathology is a rapidly evolving field embracing both conventional microscopy and molec...
Identification of driver mutations in lung adenocarcinoma has led to development of targeted agents ...
Molecular testing of cytological lung cancer specimens includes, beyond epidermal growth factor rece...
© 2018 John Wiley & Sons Ltd Background: Next generation sequencing (NGS) to detect actionable genet...
BACKGROUND: Personalized oncology requires molecular analysis of tumor cells. Several studies have d...
Background: Next-generation sequencing (NGS) in lung cancer specimens from endobronchial ultrasound ...
The handling of biomaterials is crucial for precision medicine in advanced-stage lung patients with ...
BACKGROUND Molecular testing of lung adenocarcinomas (ADCs) is crucial for therapy stratification of...
Background: With the increase in need for further, serial, testing of lung cancer specimens, exhaust...
Background: Artificial genomic reference standards in a cytocentrifuge/cytospin format with well-ann...
BACKGROUND: Artificial genomic reference standards in a cytocentrifuge/cytospin format with well-ann...
Background: Biomarker-driven clinical trials in advanced non-small cell lung cancer (NSCLC) usually ...
In the era of personalised medicine, testing for an increasing number of predictive biomarkers is be...
BACKGROUND: Molecular testing of cytological lung cancer specimens includes, beyond epidermal growth...
In addition to conventional cytology, liquid-based cytology (LBC) is also used for immunocytochemist...
Molecular cytopathology is a rapidly evolving field embracing both conventional microscopy and molec...
Identification of driver mutations in lung adenocarcinoma has led to development of targeted agents ...
Molecular testing of cytological lung cancer specimens includes, beyond epidermal growth factor rece...
© 2018 John Wiley & Sons Ltd Background: Next generation sequencing (NGS) to detect actionable genet...
BACKGROUND: Personalized oncology requires molecular analysis of tumor cells. Several studies have d...
Background: Next-generation sequencing (NGS) in lung cancer specimens from endobronchial ultrasound ...
The handling of biomaterials is crucial for precision medicine in advanced-stage lung patients with ...
BACKGROUND Molecular testing of lung adenocarcinomas (ADCs) is crucial for therapy stratification of...
Background: With the increase in need for further, serial, testing of lung cancer specimens, exhaust...
Background: Artificial genomic reference standards in a cytocentrifuge/cytospin format with well-ann...
BACKGROUND: Artificial genomic reference standards in a cytocentrifuge/cytospin format with well-ann...
Background: Biomarker-driven clinical trials in advanced non-small cell lung cancer (NSCLC) usually ...
In the era of personalised medicine, testing for an increasing number of predictive biomarkers is be...
BACKGROUND: Molecular testing of cytological lung cancer specimens includes, beyond epidermal growth...
In addition to conventional cytology, liquid-based cytology (LBC) is also used for immunocytochemist...
Molecular cytopathology is a rapidly evolving field embracing both conventional microscopy and molec...
Identification of driver mutations in lung adenocarcinoma has led to development of targeted agents ...
Molecular testing of cytological lung cancer specimens includes, beyond epidermal growth factor rece...